J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
February 06, 2024 at 05:30 am EST
Share
J. B. Chemicals & Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 8,445.1 million compared to INR 7,927.1 million a year ago. Revenue was INR 8,518.6 million compared to INR 7,958.4 million a year ago. Net income was INR 1,335.7 million compared to INR 1,061 million a year ago. Basic earnings per share from continuing operations was INR 8.62 compared to INR 6.86 a year ago. Diluted earnings per share from continuing operations was INR 8.46 compared to INR 6.79 a year ago.
For the nine months, sales was INR 26,224.5 million compared to INR 23,869.6 million a year ago. Revenue was INR 26,430.9 million compared to INR 23,923.2 million a year ago. Net income was INR 4,264.7 million compared to INR 3,222.1 million a year ago. Basic earnings per share from continuing operations was INR 27.53 compared to INR 20.84 a year ago. Diluted earnings per share from continuing operations was INR 27.04 compared to INR 20.61 a year ago.
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.